Methods for treatment of headaches by administration of oxytocin
AssigneesThe Board of Trustees of the Leland Stanford Junior University, Trigemina, Inc., HealthPartners Research Foundation
InventorsDavid C. YEOMANS, Martin S. ANGST, William H. FREY, II, Daniel I. JACOBS
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for the treatment of headache and headache disorders. The methods comprise administration of an oxytocin peptide for the treatment of primary and secondary headaches or trigeminal neuralgia.
Claims35
A method for the treatment of headache pain comprising administering to an individual in need thereof an effective dose of an oxytocin peptide, wherein the headache pain is a result of a primary type headache or a result of trigeminal neuralgia.
A method for the treatment of migraine headache pain comprising administering to an individual in need thereof an effective dose of an oxytocin peptide wherein the oxytocin peptide is administered via intranasal administration.
A method for the treatment of cluster headache pain comprising administering to an individual in need thereof an effective dose of an oxytocin peptide wherein the oxytocin peptide is administered via intranasal administration.
A method for the treatment of tension headache pain comprising administering to an individual in need thereof an effective dose of an oxytocin peptide wherein the oxytocin peptide is administered via intranasal administration.
A method for the treatment of trigeminal neuralgia comprising administering to an individual in need thereof an effective dose of an oxytocin peptide wherein the oxytocin peptide is administered via intranasal administration.
Dependencies are inferred from the claim text.